Print
Email
Print Edition StoriesWednesday, February 3, 2010
Raindance appoints Banerjee CEO
By Mass High Tech staff
MHT's Julie Donnelly: Pharmaceuticals find drug development partners in colleges
MHT's Galen Moore: Honoring innovation in New England
MHT's Galen Moore: Hiring trends and opportunities
Lexington-based drug discovery toolmaker Raindance Technologies Inc. has named Sirshendu Roopom Banerjee its new president and CEO. Banerjee replaces Christopher McNary, who has held the position since November 2007, and will take the role of chief commercial officer.
Banerjee joins Raindance having most recently served as director of health-care investment banking at Leerink Swann, leading Life Science Tools and Diagnostics. Prior to Leerink Swann, he worked for Goldman Sachs, advising Fortune 500 health-care firms about global expansion, mergers and acquisitions, growth strategy and product development and launch strategy. He has also previously worked for the Dana Farber Cancer Institute, the Whitehead Institute/MIT Human Genome Project and Mass General Hospital Cancer Center. Banerjee graduated with an M.P.P. from Harvard University’s Kennedy School of Government and two bachelor of science degrees in biology and economics from MIT.
Raindance Technologies makes and sells microdroplet-based devices and related tools to accelerate human health and disease research.
The privately held company raised $6 million last May, of a proposed $12 million round. The company was a recipient in December 2008 of a three-year Massachusetts Life Sciences Center grant, valued at 250,000 per year, to develop an individual cell data collector via a fluorescence-activated cell sorter.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
